FDA Drug recall D-1570-2014
Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt
- FDA Drug
- Class III
- terminated
- Published 2014-09-24
On 2014-09-24 the FDA classified a Class III recall of Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt by Apotex, citing failed Impurity/Degradation Specification; high out of specification for CAD II degradant.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1570-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-08-21 |
| Published | 2014-09-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Apotex |
| Distribution | US |
Product
Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9
Reason
Failed Impurity/Degradation Specification; high out of specification for CAD II degradant
Identifiers
| upc | 360505375998 |
|---|---|
| code_info | Lot # KK6086, exp 03/2015, UPC 360505375998. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1570-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.